Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Sep 16, 2008

MIP Technologies and Lund University Obtain About $382.65K to Develop Polymers that Resemble Biological Molecules

  • MIP Technologies will collaborate with Lund University to develop polymer materials under funding from the Swedish Research Council. The organizations will receive €270,000, or  roughly $382,658 over the next four years.

    The project between MIP and the department of physical chemistry 1 at the university is designed to explore and develop methods for production of smart polymers that mimic functionalities and properties of biological macromolecules such as proteins, enzymes, and antibodies.

    The research will initially focus on structure-performance relationships in known bio macromolecules. Then, the active chemical functionalities will be built into new synthetic materials via polymerization in structured dispersed media.

    “The field of artificial proteins is at an early stage but developments in this project may see, in the future, the substitution of antibodies and other therapeutic proteins by truly artificial bioactive entities,” states Anthony Rees, CEO at MIP Technologies.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »